CARM icon

Carisma Therapeutics
CARM

Overview Fund Activity

46 hedge funds and large institutions have $18.8M invested in Carisma Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+9
Holders Change %
+24.32%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
14
Reduced
7
Closed
6
Calls
$1.74M
Puts
$219K
Net Calls
+$1.52M
Net Calls Change
-$193K

Top Buyers

1
EP
1
Eversept Partners
New York
$1.35M
2
BlackRock
2
BlackRock
New York
$2.23M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$672K
4
Qube Research & Technologies (QRT)
4
Qube Research & Technologies (QRT)
United Kingdom
$261K
5
CS
5
Credit Suisse
Switzerland
$261K

Top Sellers

1
CH
1
CVI Holdings
Delaware
$0
2
KCM
2
Kingdon Capital Management
New York
$1.92M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$0
4
Wells Fargo
4
Wells Fargo
California
$1K
5
MTIM
5
Marathon Trading Investment Management
Pennsylvania
$14K
Name Holding Trade Value Shares
Change 		Shares
Change %
CG
51
Cutler Group
California
– -$1K -55 Closed
1 2
3